The present invention relates to a combination of lipoic acid and taurine for use as an osmoprotective agent for the prevention and treatment of ailments of the skin and of the mucous membranes associated with osmotic imbalance. It also relates to a method for preventing and treating ailments of the skin and of the mucous membranes associated with osmotic imbalance, in which an appropriate amount of a combination of lipoic acid and taurine is applied to the skin or the mucous membranes of a patient who is in need thereof. The invention also relates to a pharmaceutical or cosmetic composition suitable for topical application or an oph-thalmic composition which comprises a combination oflipoic acid and taurine.

Described herein is a composition of matter comprising i) at least one compound of formula (I) ##STR00001## in the form of any of its stereoisomers; and wherein R.sup.1 represents a phenyl group optionally substituted by one or two C.sub.1-3 alkyl or alkoxy groups or by one or two halides group; R.sup.2 and R.sup.3 represent, independently from each other a heterocyclic group comprising from 1 to 3 heteroatoms selected from nitrogen, oxygen and sulfur, optionally substituted by one or two C.sub.1-3 alkyl groups; and ii) at least a C.sub.1-6 linear or branched alkyl lactate. Also described herein is a method of using the composition of matter as part of a flavoring or perfuming composition or of a flavoring or perfuming consumer product. Also described herein is a process to prepare the composition of matter and the polymorph of compound of formula (I).

Methods and compositions for rapid and efficient assembly of substrates (e.g., fibers) coated with lamellar vesicles are provided, wherein the vesicles are more strongly attached to the substrate than those made using other methods.

The present invention provides compounds as PPAR agonists and their application, involving a new class of peroxisome proliferator-activated receptor (PPAR) gamma receptor agonist, which can inhibit the production of mitochondrial reactive oxygen species, and most of which can readily cross the blood-brain barrier. The present invention also includes pharmaceutical uses of the compounds.

The disclosure relates to methods for coloring keratinous substrates using solubilized vat dyes, as well as compositions and kits suitable for carrying out the methods. The disclosure also relates to novel solubilized vat dyes.

The present invention relates to a compound represented by the following formula (I):

A[B—(C).sub.v].sub.w  (I), wherein A is a photoprotective moiety, B is a linker, C is a functional group, v is an integer from 1 to 2000, and w is an integer from 1 to 6. It also relates to a composition comprising the same and, more particularly, to a cosmetic or a sunscreen composition. It also relates to the use of such compounds in cosmetic and therapeutic applications. The invention also relates to the use of such compounds for reducing photodegradation and/or photoinstability of pharmaceuticals and cosmetics. The invention further relates to a material comprising a support and such a compound adhered to said support.

A liquid compositions comprising at least one non-natural cooling compound and lactic acid, and the use of said composition in a flavour or fragrance composition.

Compositions comprising at least one cooling compound and a solvent, and the use of said composition in a flavour or fragrance composition.

Among the various aspects of the present disclosure is the provision of compositions and methods for treating hair regeneration disorders or conditions such as hair loss or thinning. An aspect of the present disclosure provides for a method of treating hair loss, promoting hair growth, or treating hair loss, such as alopecia or telogen effluvium, comprising administering a TRPV4 activating agent to a subject.

The present invention relates to the use of iminooxothiazolidine derivatives for preventing or treating hair growth disorders. The iminooxothiazolidine derivatives may be formulated as compositions suitable for either the systemic administration or the local application to the scalp.